HMGB1 and cancer: (33) study also showed that ICD was significantly enhanced by upregulating CD8A and releasing HMGB1 in tumor tissues, which resulted in an enhanced role of immune cells infiltrating the tumor microenvironment after cancer antigen exposure in the presence of ICD (35, 36).